Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors

Affiliations

• ¹ Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
• ² Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
• ³ Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
• ⁴ Department of Hemato-Oncology, Belfast City Hospital, Belfast, UK.
• ⁵ Cancer Genomics, Academic Unit of Cancer Sciences, Cancer Research UK Centre and Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton, Southampton, UK.
• ⁶ Hematology Department, Hospital Clinic, Barcelona, Spain.
• ⁷ Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
• ⁸ Hematology Department, Nikea General Hospital, Pireaus, Greece.
• ⁹ Central European Institute of Technology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
• ¹⁰ Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
• ¹¹ Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
• ¹² Hematopathology Section, Laboratory of Pathology, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.
• ¹³ Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
• ¹⁴ Division of experimental Oncology, IRCCS Istituto Scientfico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
• ¹⁵ Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece. [email protected].
• ¹⁶ Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. [email protected].